weight-loss drugs – The Milli Chronicle

Saturday, November 8, 2025

Latest:

Wall Street Market Adjustments Reflect Broader Economic Considerations
Gates Foundation Commits $1.4 Billion to Support Climate-Resilient Farming
U.S. Emphasizes Energy Security Through Balanced Approach to Oil, Gas, and Renewables
US Government Launches Generous Model to Cut Medicaid Prescription Costs
Wall Street Applauds Tesla Shareholders’ Landmark Approval of Elon Musk’s $1 Trillion Performance-Based Pay Package

Factual Version of a Story

NewsDesk Milli Chronicle November 7, 2025 active pharmaceutical ingredients, API demand, API exports, API manufacturing, API production growth., biotechnology India, CDMO services, contract manufacturing, diabetes drugs, Divi’s Laboratories, Divi’s profits, drug manufacturing, Eli Lilly, European pharma, global healthcare, global pharma supply chain, Hyderabad pharma company, India drugmakers, Indian pharmaceutical exports, Novo Nordisk, pharma growth India, pharma industry trends, pharma investment, pharmaceutical innovation, pharmaceutical R&D, sustainable manufacturing, US market pharma, weight-loss drugs

Divi’s Laboratories Reports Strong Q2 Growth, Driven by Rising API Demand and Global Expansion

Hyderabad – Indian pharmaceutical giant Divi’s Laboratories outperforms expectations with a surge in profits and strong export performance amid growing

Featured News World

NewsDesk Milli Chronicle November 6, 2025November 6, 2025 affordable healthcare, American health programs, diabetes care, drug pricing reform, Eli Lilly, GLP-1 medications, healthcare accessibility, injectable treatments, Medicaid access, Medicaid benefits, medical affordability, Medicare coverage, Medicare discounts, Novo Nordisk, obesity treatment, orforglipron, pharmaceutical innovation, prescription savings, public-private partnership, Trump health deal, TrumpRx program, U.S. drug market, U.S. healthcare reform, Wegovy, weight-loss drugs, weight-loss pills, Zepbound

U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs

A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.

Bill Gates and PAHO Explore Affordable Access to Weight-Loss Drugs for Developing Nations

London – In a move that could reshape global health access, philanthropist Bill Gates and the Pan American Health Organization